Therapy News and Research

RSS

Innovative memory aid system for dementia patients

A NEW ‘home help’ website giving dementia patients timely reminders and reassuring them of key visits of family, relatives, social activities and carers is being trialled in a care home in Sheffield.

23 Aug 2013

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.

23 Aug 2013

Tufts Health Plan provides positive coverage decision and in-network provider status to bioTheranostics

bioTheranostics, a leading provider of molecular diagnostic solutions for cancer, has received a positive coverage decision and in-network provider status from Tufts Health Plan for its CancerTYPE ID molecular cancer classifier.

23 Aug 2013

Stem cell therapy improves radiation-induced cognitive impairment

Patients receiving cranial irradiation treatment for brain cancer may find the treatment life-saving, but often suffer progressive and debilitating cognitive detriments, including spatial learning and memory deficits. The cognitive deficits are a contributing factor to the often significant adverse impacts on the surviving patients' quality of life after radiation therapy. In an effort to improve post-irradiation cognitive impairment, scientists at the University of California, Irvine, and colleagues at Neuralstem, Inc. (Rockville, MD), have transplanted fetal stem cells into laboratory animals with radiation-induced cognitive impairments and found that this led to a number of cognitive improvements.

23 Aug 2013

NYU Langone Medical Center announces opening of new wound healing center

NYU Langone Medical Center announces the opening of the new Helen L. and Martin S. Kimmel Hyperbaric and Advanced Wound Healing Center at 240 East 38th Street. One of only two Hyperbaric Centers in Manhattan providing treatment to patients with chronic non-healing wounds, patients now have access to surgical and non-surgical expertise within one location.

23 Aug 2013

New technique may convert cells from heart disease patients into heart muscle cells

Researchers have developed a new technique that might one day be used to convert cells from heart disease patients into heart muscle cells that could act as a personalized treatment for their condition.

23 Aug 2013

MFDCs have advantages over adult skin cells, including proliferation and differentiation

Multipotent fetal dermal cells (MFDCs) may be an ideal source for cell therapy for repairing damaged tissues and organs. Their performance is superior to that of adult dermal cells, said a research team in Italy that developed a cell isolation technique for MFDCs and subsequently published a study that appears as an early e-publication for the journal Cell Transplantation.

23 Aug 2013

New radiation treatment can reduce bone pain, extend lives of prostate cancer patients

Prostate cancer that has spread to the bones can cause pain and fractures. Loyola University Medical Center is among the first hospitals in Chicago to offer a new targeted radiation treatment that can reduce bone pain and the incidence of fractures - and also extend patients' lives.

23 Aug 2013

Seven researchers to receive grants from ASTRO to advance radiation oncology research

The American Society for Radiation Oncology (ASTRO) has selected seven (7) leading researchers who will receive a total of $675,000 in awards and grants to advance radiation oncology research.

23 Aug 2013

Drug to treat blood cancers may also stop spread of invasive breast cancer

A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered. Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 (PRKD1) that halts the ability of cancer cells to separate from a tumor and spread to distant organs.

23 Aug 2013

Study: Gene variants linked with increased risk for kidney complications in patients with lupus

Variants in a particular gene are linked with an increased risk for kidney complications in patients with lupus, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The findings could lead to better treatments to protect the kidney health of patients with the disease.

23 Aug 2013

Noninvasive urine test can accurately monitor risk of kidney rejection

Levels of a protein in the urine of kidney transplant recipients can distinguish those at low risk of developing kidney injury from those at high risk, a study suggests. The results also suggest that low levels of this protein, called CXCL9, can rule out rejection as a cause of kidney injury.

23 Aug 2013

Aromatherapy, IV dextrose may relieve nausea and vomiting after surgery

Two simple, non-drug treatments-aromatherapy and intravenous administration of a simple sugar solution-may offer effective new approaches to relieving nausea and vomiting after surgery, report a pair of studies in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

22 Aug 2013

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Takeda Pharmaceutical Company Limited today announced that results from two Phase 3 studies evaluating vedolizumab, an investigational humanized monoclonal antibody, for the treatment of adults with moderately to severely active ulcerative colitis and Crohn’s disease, were published in the August 22, 2013 issue of the New England Journal of Medicine.

22 Aug 2013

Use of psychotherapy on a clear decline in US

Psychotherapy has issues. Evidence shows that some psychosocial treatments work well for common mental health problems such as anxiety and depression and that consumers often prefer them to medication.

22 Aug 2013

Overwhelming fear in children may be a sign of separation anxiety disorder

Most children experience some degree of apprehension and excitement as the first day of school approaches, but what does it mean when a child is overcome with fear at the thought of separating from parents and caregivers to go to class? This overwhelming fear may be a sign of separation anxiety disorder, a condition characterized by a school-aged child's extreme fear and nervousness of separating from loved ones.

22 Aug 2013

Virtual 3-D heart model analyzes defibrillator placement in children born with heart defects

The small size and abnormal anatomy of children born with heart defects often force doctors to place lifesaving defibrillators entirely outside the heart, rather than partly inside — a less-than-ideal solution to dangerous heart rhythms that involves a degree of guesstimating and can compromise therapy.

22 Aug 2013

New antibody drug shows positive results for treating Crohn's disease, ulcerative colitis

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of Medicine (NEJM).

22 Aug 2013

DFID awards 5-year grant to DNDi to advance research and development for neglected diseases

The UK Department for International Development (DFID) has announced its renewed support to the Drugs for Neglected Diseases initiative (DNDi), allocating a total of - 30 million (- 35 million) over the coming five years (2013-2018) to DNDi's Research & Development (R&D) portfolio to fight neglected diseases.

22 Aug 2013

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

The U.S. Food and Drug Administration today allowed marketing in the U.S. of the first mass spectrometer system for automated identification of bacteria and yeasts that are known to cause serious illness in humans.

22 Aug 2013

Therapy News and Research

Innovative memory aid system for dementia patients

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Tufts Health Plan provides positive coverage decision and in-network provider status to bioTheranostics

Stem cell therapy improves radiation-induced cognitive impairment

NYU Langone Medical Center announces opening of new wound healing center

New technique may convert cells from heart disease patients into heart muscle cells

MFDCs have advantages over adult skin cells, including proliferation and differentiation

New radiation treatment can reduce bone pain, extend lives of prostate cancer patients

Seven researchers to receive grants from ASTRO to advance radiation oncology research

Drug to treat blood cancers may also stop spread of invasive breast cancer

Study: Gene variants linked with increased risk for kidney complications in patients with lupus

Noninvasive urine test can accurately monitor risk of kidney rejection

Aromatherapy, IV dextrose may relieve nausea and vomiting after surgery

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Use of psychotherapy on a clear decline in US

Overwhelming fear in children may be a sign of separation anxiety disorder

Virtual 3-D heart model analyzes defibrillator placement in children born with heart defects

New antibody drug shows positive results for treating Crohn's disease, ulcerative colitis

DFID awards 5-year grant to DNDi to advance research and development for neglected diseases

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News